Chiesi’s priorities focus on propelling innovation in Mexico by breaking bureaucratic barriers that slow progress.

After several accusations against the AstraZeneca and Johnson & Johnson vaccines, immunization campaigns slow down.

To compete in a changing market, RGA is integrating added-value services and predictive models that respond to users’ realities.

Side effects have put on hold the use of different COVID-19 vaccines. Meanwhile, Mexico keeps going with the development of its own vaccine.

National vaccine developments move forward and promise affordable, quality immunization against COVID-19.

Mexico’s top position as a medical devices manufacturer can be strengthened by increasing domestic consumption.

From laboratory support to direct contact with patients, tech giants have now made their way into the health sector.

To ensure treatment continuity and prevent COVID-19 contagion, CMPH divided its operations to provide quality care on both fronts.

Mexico’s vaccination plan keeps moving forward with the country reaching 10.6 million first doses administered. When can we move to the next stage?